Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Die Ophthalmologie
Erschienen in: Der Ophthalmologe 7/2016

29.06.2016 | Konjunktivitis | Das therapeutische Prinzip

Impfschäden am Auge

verfasst von: PD Dr. T. Ness, Prof. Dr. H. Hengel

Erschienen in: Die Ophthalmologie | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Impfungen sind eine sehr erfolgreiche Maßnahme, um vorbeugend gegen Infektionen zu schützen. Sie werden aber auch mit einer Vielzahl von Impfnebenwirkungen in Verbindung gebracht. Nur wenige dieser Impfnebenwirkungen betreffen das Auge und sind nachweislich mit einer Impfung verbunden. Hierzu zählen die Konjunktivitis im Rahmen der üblichen Impfreaktion und der Impfkrankheit nach Impfung mit Lebendviren sowie das okulorespiratorische Syndrom/„serum-sickness syndrome“ nach Influenzaimpfung. Eine Reaktivierung/Förderung von Autoimmunerkrankungen, z. B. einer Uveitis, lässt sich nicht ausschließen, ein sicherer Nachweis hierfür ist aber bislang nicht erfolgt. Der Nutzen der von der Ständigen Impfkommission (STIKO) empfohlenen Impfungen überwiegt aber das geringe Risiko okulärer Nebenwirkungen deutlich.
Literatur
1.
Panhuis WG van, Grefenstette J, Jung SY, Chok NS, Cross A, Eng H et al (2013) Contagious diseases in the United States from 1888 to the present. N Engl J Med 369:2152–2158. doi:10.1056/NEJMms1215400PubMedPubMedCentralCrossRef
2.
3.
Brigitte Keller-Stanislawski KH (2002) Auswertung der Meldungen von Verdachtsfällen auf Impfkomplikationen nach dem Infektionsschutzgesetz. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 45:344–354CrossRef
4.
Härmark L, Hunsel F van, Grundmark B (2015) ADR reporting by the general public: Lessons learnt from the dutch and Swedish systems. Drug Saf 38:337–347. doi:10.1007/s40264-015-0264-1PubMedCrossRef
5.
Mansour DEAA, El-Shazly AA-F, Elawamry AI, Ismail AT (2012) Comparison of ocular findings in patients with H1N1 influenza infection versus patients receiving influenza vaccine during a pandemic. Ophthalmic Res 48:134–138. doi:10.1159/000337138PubMedCrossRef
6.
Choe YJ, Eom HS, Bae G‑R (2014) Vaccine-associated measles in the low-incidence country of Korea over a 10-year period. Jpn J Infect Dis 67:180–183PubMedCrossRef
7.
Fredette MJ, De Serres G, Malenfant M (2003) Ophthalmological and biological features of the oculorespiratory syndrome after influenza vaccination. Clin Infect Dis 37:1136–1138. doi:10.1086/378294PubMedCrossRef
8.
Scott S, Cutts FT, Nyandu B (1999) Mild illness at or after measles vaccination does not reduce seroresponse in young children. Vaccine 17:837–843PubMedCrossRef
9.
Kitaichi N, Ariga T, Ohno S, Shimizu T (2006) Acute unilateral conjunctivitis after rubella vaccination: the detection of the rubella genome in the inflamed conjunctiva by reverse transcriptase-polymerase-chain reaction. Br J Ophthalmol 90:1436–1437. doi:10.1136/bjo.2006.096008PubMedPubMedCentralCrossRef
10.
Lewis FMT, Chernak E, Goldman E, Li Y, Karem K, Damon IK et al (2004) Ocular vaccinia infection in laboratory worker, Philadelphia. Emerg Infect Dis 2006(12):134–137. doi:10.3201/eid1201.051126
11.
Fillmore GL, Ward TP, Bower KS, Dudenhoefer EJ, Grabenstein JD, Berry GK et al (2004) Ocular complications in the Department of Defense Smallpox Vaccination Program. Ophthalmology 111:2086–2093. doi:10.1016/j.ophtha.2004.04.027PubMedCrossRef
12.
Hu G, Wang MJ, Miller MJ, Holland GN, Bruckner DA, Civen R et al (2004) Ocular vaccinia following exposure to a smallpox vaccinee. Am J Ophthalmol 137:554–556. doi:10.1016/j.ajo.2003.09.013PubMedCrossRef
13.
Hoorbakht H, Bagherkashi F (2012) Optic neuritis, its differential diagnosis and management. Open Ophthalmol J 6:65–72. doi:10.2174/1874364101206010065PubMedPubMedCentralCrossRef
14.
Schattner A (2005) Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 23:3876–3886. doi:10.1016/j.vaccine.2005.03.005PubMedCrossRef
15.
Massilamany C, Koenig A, Reddy J, Huber S, Buskiewicz I (2015) Autoimmunity in picornavirus infections. Curr Opin Virol 16:8–14. doi:10.1016/j.coviro.2015.10.004PubMedCrossRef
16.
Venkatesan A, Benavides DR (2015) Autoimmune encephalitis and its relation to infection. Curr Neurol Neurosci Rep 15:3. doi:10.1007/s11910-015-0529-1PubMedCrossRef
17.
Salemi S, D’Amelio R (2010) Could autoimmunity be induced by vaccination? Int Rev Immunol 29:247–269. doi:10.3109/08830181003746304PubMedCrossRef
18.
Stübgen J‑P (2013) A literature review on optic neuritis following vaccination against virus infections. Autoimmun Rev 12:990–997. doi:10.1016/j.autrev.2013.03.012PubMedCrossRef
19.
Payne DC, Rose CE, Kerrison J, Aranas A, Duderstadt S, McNeil MM (2006) Anthrax vaccination and risk of optic neuritis in the United States military, 1998–2003. Arch Neurol 63:871–875. doi:10.1001/archneur.63.6.871PubMedCrossRef
20.
Nass M (2006) Data vs conclusions in the optic neuritis vaccination investigation. Arch Neurol 63:1809–1810 (author reply 1810). doi:10.1001/archneur.63.12.1809PubMedCrossRef
21.
Engler RJM, Klote M, Nelson MR (2007) Optic neuritis and vaccination investigation: failure to consider significant sex differences and multiple vaccine combinations. Arch Neurol 64:1674–1675 (1673–1674; discussion). doi:10.1001/archneur.64.11.1673CrossRef
22.
Committee to Review Adverse Effects of Vaccines, Institute of Medicine (2011) Adverse Effects of Vaccines: Evidence and Causality [Internet]. Stratton K, Ford A, Rusch E, Clayton EW, editors. Washington (DC): National Academies Press (US). http://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK190024/​ Zugegriffen: 5. Jan 2016
23.
Crawford CM, Igboeli O (2013) A review of the inflammatory chorioretinopathies: The white dot syndromes. ISRN Inflamm 2013:1–9. doi:10.1155/2013/783190CrossRef
24.
Skowronski DM, Strauss B, Kendall P, Duval B, De Serres G (2002) Low risk of recurrence of oculorespiratory syndrome following influenza revaccination. CMAJ 167: 853:858
25.
Skowronski DM, De Serres G, Scheifele D, Russell ML, Warrington R, Davies HD et al (2003) Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected. Clin Infect Dis 37:1059–1066. doi:10.1086/378274PubMedCrossRef
26.
Skowronski DM, Bjornson G, Husain E, Metzger DL, Scheifele DW (2005) Oculorespiratory syndrome after influenza immunization in children. Pediatr Infect Dis J 24:63–69PubMedCrossRef
27.
De Serres G, Skowronski DM, Guay M, Rochette L, Jacobsen K, Fuller T et al (2004) Recurrence risk of oculorespiratory syndrome after influenza vaccination: Randomized controlled trial of previously affected persons. Arch Intern Med 164:2266–2272. doi:10.1001/archinte.164.20.2266PubMedCrossRef
28.
Cooper C, Thorne A (2011) Canadian Institutes of Health Research-Canadian HIV Trials Network (CTN) Influenza Vaccine Research Group. Influenza vaccine oculorespiratory syndrome incidence is reduced in HIV. Vaccine 29:7876–7877. doi:10.1016/j.vaccine.2011.08.066PubMedCrossRef
29.
De Serres G, Grenier JL, Toth E, Ménard S, Roussel R, Tremblay M et al (2003) The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination. Vaccine 21:2354–2361PubMedCrossRef
30.
De Serres G, Toth E, Ménard S, Grenier JL, Roussel R, Tremblay M et al (2005) Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons. Vaccine 23:3726–3732. doi:10.1016/j.vaccine.2005.01.154PubMedCrossRef
31.
De Serres G, Boulianne N, Duval B, Rochette L, Grenier JL, Roussel R et al (2003) Oculo-respiratory syndrome following influenza vaccination: Evidence for occurrence with more than one influenza vaccine. Vaccine 21:2346–2353PubMedCrossRef
32.
Chiong FJK, Loewenthal M, Boyle M, Attia J (2015) Serum sickness-like reaction after influenza vaccination. BMJ Case Rep 2015. doi:10.1136/bcr-2015-211917
33.
Bonds RS, Kelly BC (2013) Severe serum sickness after H1N1 influenza vaccination. Am J Med Sci 345:412–413. doi:10.1097/MAJ.0b013e318273de7fPubMedCrossRef
34.
Apisarnthanarak A, Uyeki TM, Miller ER, Mundy LM (2009) Serum sickness-like reaction associated with inactivated influenza vaccination among Thai health care personnel: risk factors and outcomes. Clin Infect Dis 49:18–22. doi:10.1086/599615CrossRef
35.
Payne DC, Rose CE, Kerrison J, Aranas A, Duderstadt S, McNeil MM (2006) Anthrax vaccination and risk of optic neuritis in the United States military, 1998–2003. Arch Neurol 63:871–875. doi:10.1001/archneur.63.6.871PubMedCrossRef
36.
Geier DA, Geier MR (2005) A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 38:295–301PubMedCrossRef
37.
DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB et al (2003) Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 60:504–509. doi:10.1001/archneur.60.4.504PubMedCrossRef
38.
Mikaeloff Y, Caridade G, Suissa S, Tardieu M (2009) Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 72:873–880. doi:10.1212/01.wnl.0000335762.42177.07PubMedCrossRef
39.
Fraunfelder FW, Suhler EB, Fraunfelder FT (2010) Hepatitis B vaccine and uveitis: An emerging hypothesis suggested by review of 32 case reports. Cutan Ocul Toxicol 29:26–29. doi:10.3109/15569520903427717PubMedCrossRef
40.
Cerpa-Cruz S, Paredes-Casillas P, Landeros Navarro E, Bernard-Medina AG, Martínez-Bonilla G, Gutiérrez-Ureña S (2013) Adverse events following immunization with vaccines containing adjuvants. Immunol Res 56:299–303. doi:10.1007/s12026-013-8400-4PubMedCrossRef
41.
Esposito S, Prada E, Mastrolia MV, Tarantino G, Codecà C, Rigante D (2014) Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background. Immunol Res 60:366–375. doi:10.1007/s12026-014-8586-0PubMedCrossRef
42.
Hwang CW, Steigleman WA, Saucedo-Sanchez E, Tuli SS (2013) Reactivation of herpes zoster keratitis in an adult after varicella zoster vaccination. Cornea 32:508–509. doi:10.1097/ICO.0b013e318277acaePubMedCrossRef
43.
Charkoudian LD, Kaiser GM, Steinmetz RL, Srivastava SK (2011) Acute retinal necrosis after herpes zoster vaccination. Arch Ophthalmol 129:1495–1497 (Chic Ill 1960). doi:10.1001/archophthalmol.2011.320PubMedCrossRef
44.
Gonzales JA, Levison AL, Stewart JM, Acharya NR, Margolis TP (2012) Retinal necrosis following varicella-zoster vaccination. Arch Ophthalmol 130:1355–1356 (Chic Ill 1960). doi:10.1001/archophthalmol.2012.2255PubMedCrossRef
45.
Nagpal A, Vora R, Margolis TP, Acharya NR (2009) Interstitial keratitis following varicella vaccination. Arch Ophthalmol 127(2):222–223 (Chic Ill 1960). doi:10.1001/archophthalmol.2008.569PubMedCrossRef
46.
Khalifa YM, Jacoby RM, Margolis TP (2010) Exacerbation of zoster interstitial keratitis after zoster vaccination in an adult. Arch Ophthalmol 128:1079–1080 (Chic Ill 1960). doi:10.1001/archophthalmol.2010.142PubMedCrossRef
47.
Lin P, Yoon MK, Chiu CS (2009) Herpes zoster keratouveitis and inflammatory ocular hypertension 8 years after varicella vaccination. Ocul Immunol Inflamm 17:33–35. doi:10.1080/09273940802491892PubMedCrossRef
48.
Naseri A, Good WV, Cunningham ET (2003) Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination. Am J Ophthalmol 135:415–417PubMedCrossRef
49.
Sham CW, Levinson RD (2012) Uveitis exacerbation after varicella-zoster vaccination in an adult. Arch Ophthalmol 130:793–794 (Chic Ill 1960). doi:10.1001/archophthalmol.2011.1881PubMedCrossRef
50.
Esmaeli-Gutstein B, Winkelman JZ (1999) Uveitis associated with varicella virus vaccine. Am J Ophthalmol 127:733–734PubMedCrossRef
51.
Islam SM, El-Sheikh HF, Tabbara KF (2000) Anterior uveitis following combined vaccination for measles, mumps and rubella (MMR): A report of two cases. Acta Ophthalmol Scand 78:590–592PubMedCrossRef
52.
Sedaghat M, Zarei-Ghanavati S, Shokoohi S, Ghasemi A (2007) Panuveitis and dermal vasculitis following MMR vaccination. East Mediterr Health J 13:470–474 (Rev Santé Méditerranée Orient Al-Majallah Al-Sihhīyah Li-Sharq Al-Mutawassiṭ.)PubMed
53.
Chan CC, Sogg RL, Steinman L (1980) Isolated oculomotor palsy after measles immunization. Am J Ophthalmol 89:446–448PubMedCrossRef
54.
McCormick A, Dinakaran S, Bhola R, Rennie IG (2001) Recurrent sixth nerve palsy following measles mumps rubella vaccination. Eye 15:356–357. doi:10.1038/eye.2001.122PubMedCrossRef
55.
Werner DB, Savino PJ, Schatz NJ (1983) Benign recurrent sixth nerve palsies in childhood. Secondary to immunization or viral illness. Arch Ophthalmol 101:607–608 (Chic Ill 1960.)PubMedCrossRef
56.
Dolinová L (1974) Bilateral uveoretinoneuritis following DITEPE vaccination. Ceskoslovenská Oftalmol 30:114–116
57.
Steinemann TL, Koffler BH, Jennings CD (1988) Corneal allograft rejection following immunization. Am J Ophthalmol 106:575–578PubMedCrossRef
58.
Cohen SM (2009) Multiple Evanescent White Dot Syndrome After Vaccination for Human Papilloma Virus and Meningococcus. J Pediatr Ophthalmol Strabismus. doi:10.3928/01913913-20090616-01PubMed
59.
Laria C, Alió J, Rodríguez JL, Sánchez J, Galal A (2006) Optic neuritis after meningococcal vaccination. Arch Soc Esp Oftalmol 81:479–482PubMedCrossRef
60.
Yang DS, Hilford DJ, Conrad D (2005) Acute posterior multifocal placoid pigment epitheliopathy after meningococcal C conjugate vaccine. Clin Experiment Ophthalmol 33:219–221. doi:10.1111/j.1442-9071.2005.00995.xPubMedCrossRef
61.
Dansingani KK, Suzuki M, Naysan J, Samson CM, Spaide RF, Fisher YL (2015) Panuveitis with exudative retinal detachments after vaccination against human Papilloma virus. Ophthalmic Surg Lasers Imaging Retina 46:967–970. doi:10.3928/23258160-20151008-11PubMedCrossRef
62.
Holt HD, Hinkle DM, Falk NS, Fraunfelder FT, Fraunfelder FW (2014) Human papilloma virus vaccine associated uveitis. Curr Drug Saf 9:65–68PubMedCrossRef
63.
Ogino K, Kishi S, Yoshimura N (2014) Multiple evanescent white dot syndrome after human papillomavirus vaccination. Case Rep Ophthalmol 5:38–43. doi:10.1159/000358870PubMedPubMedCentralCrossRef
64.
Geier DA, Geier MR (2015) A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events. Clin Rheumatol 34:1225–1231. doi:10.1007/s10067-014-2846-1PubMedCrossRef
65.
Escott S, Tarabishy AB, Davidorf FH (2013) Multifocal choroiditis following simultaneous hepatitis A, typhoid, and yellow fever vaccination. Clin Ophthalmol Auckl Nz 7:363–365. doi:10.2147/OPTH.S37443CrossRef
66.
Stangos A, Zaninetti M, Petropoulos I, Baglivo E, Pournaras C (2006) Multiple evanescent white dot syndrome following simultaneous hepatitis-A and yellow fever vaccination. Ocul Immunol Inflamm 14:301–304. doi:10.1080/09273940600932311PubMedCrossRef
67.
Voigt U, Baum U, Behrendt W, Hegemann S, Terborg C, Strobel J (2001) Neuritis of the optic nerve after vaccinations against hepatitis A, hepatitis B and yellow fever. Klin Monatsblätter Augenheilkd 218:688–690. doi:10.1055/s-2001-18392CrossRef
68.
Doser AK, Hartmann K, Fleisch F, Kuhn M (2002) Suspected neurological side-effects of tick-borne meningoencephalitis vaccination: experiences of the swiss adverse drug reaction reporting center. Praxis 91:159–162. doi:10.1024/0369-8394.91.5.159PubMedCrossRef
69.
Demicheli V, Debalini MG, Rivetti A (2009) Vaccines for preventing tick-borne encephalitis. Cochrane Database Syst Rev. doi:10.1002/14651858.CD000977.pub2PubMed
70.
Grzeszczuk A, Sokolewicz-Bobrowska E, Prokopowicz D (1998) Adverse reactions to tick-borne encephalitis vaccine: FSME-Immun. Infection 26:385–388PubMedCrossRef
71.
Hofmann H (1995) After vaccination for tick-borne encephalitis must onset of neurologic disorders be expected? Wien Klin Wochenschr 107:509–515PubMed
72.
Geier MR, Geier DA (2004) A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol 22:749–755PubMed
73.
Fledelius HC (1999) Unilateral papilloedema after hepatitis B vaccination in a migraine patient. A case report including forensic aspects. Acta Ophthalmol Scand 77:722–724PubMedCrossRef
74.
Erguven M, Guven S, Akyuz U, Bilgiç O, Laloglu F (2009) Optic neuritis following hepatitis B vaccination in a 9‑year-old girl. J Chin Med Assoc Jcma 72:594–597. doi:10.1016/S1726-4901(09)70435-6PubMedCrossRef
75.
Roussat B, Gohier P, Doummar D, Iba-Zizen MT, Barbat V, Jarry D et al (2001) Acute optic neuritis in children: clinical features and treatment. A study of 28 eyes in 20 children. J Fr Ophtalmol 24:36–44PubMed
76.
Fried M, Conen D, Conzelmann M, Steinemann E (1987) Uveitis after hepatitis B vaccination. Lancet 2:631–632PubMedCrossRef
77.
Brézin AP, Massin-Korobelnik P, Boudin M, Gaudric A, LeHoang P (1995) Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch Ophthalmol 113:297–300 (Chic Ill 1960)PubMedCrossRef
78.
Bourges JL, Pisella PJ, Laurens C, Limon S (1998) Multifocal placoid epitheliopathy and anti-hepatitis B vaccination. J Fr Ophtalmol 21:696–700PubMed
79.
Baglivo E, Safran AB, Borruat FX (1996) Multiple evanescent white dot syndrome after hepatitis B vaccine. Am J Ophthalmol 122:431–432PubMedCrossRef
80.
Fine L, Fine A, Cunningham ET Jr. (2001) Multiple evanescent white dot syndrome following hepatitis a vaccination. Arch Ophthalmol 119:1856–1858PubMedCrossRef
81.
Berkman N (1997) A case of segmentary unilateral occlusion of the central retinal vein following hepatitis B vaccinatio. Press Médicale 26:670 (Paris Fr 1983)
82.
Devin F, Roques G, Disdier P, Rodor F, Weiller PJ (1996) Occlusion of central retinal vein after hepatitis B vaccination. Lancet 347:1626PubMedCrossRef
83.
Ferrini W, Aubert V, Balmer A, Munier FL, Abouzeid H (2013) Anterior uveitis and cataract after rubella vaccination: A case report of a 12-month-old girl. Pediatrics 132:1035–1038. doi:10.1542/peds.2012–2930CrossRef
84.
Werner DB, Savino PJ, Schatz NJ (1983) Benign recurrent sixth nerve palsies in childhood. Secondary to immunization or viral illness. Arch Ophthalmol 101:607–608 (Chic Ill 1960)PubMedCrossRef
85.
Kazarian EL, Gager WE (1978) Optic neuritis complicating measles, mumps, and rubella vaccination. Am J Ophthalmol 86:544–547PubMedCrossRef
86.
Marshall GS, Wright PF, Fenichel GM, Karzon DT (1985) Diffuse retinopathy following measles, mumps, and rubella vaccination. Pediatrics 76:989–991PubMed
87.
Han SB, Hwang J‑M, Kim J‑S, Yang HK (2014) Optic neuritis following Varicella zoster vaccination: Report of two cases. Vaccine 32:4881–4884. doi:10.1016/j.vaccine.2014.07.023PubMedCrossRef
88.
Naseri A, Good WV, Cunningham ET (2003) Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination. Am J Ophthalmol 135:415–417PubMedCrossRef
89.
Fine HF, Kim E, Flynn TE, Gomes NL, Chang S (2010) Acute posterior multifocal placoid pigment epitheliopathy following varicella vaccination. Br J Ophthalmol 94(3):282–283. doi:10.1136/bjo.2008.144501PubMedCrossRef
90.
Holt HD, Hinkle DM, Falk NS, Fraunfelder FT, Fraunfelder FW (2014) Human papilloma virus vaccine associated uveitis. Curr Drug Saf 9:65–68PubMedCrossRef
91.
Skowronski DM, De Serres G, Scheifele D, Russell ML, Warrington R, Davies HD et al (2003) Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected. Clin Infect Dis 37:1059–1066. doi:10.1086/378274PubMedCrossRef
92.
Choudhri Y, Walop W, Squires S, Tam T, King A, Skowronski D et al (2002) ORS during the 2000–2001 influenza vaccination season. Can Commun Dis 28:2–8
93.
De Serres G, Grenier JL, Toth E, Ménard S, Roussel R, Tremblay M et al (2003) The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination. Vaccine 21:2354–2361PubMedCrossRef
94.
Grenier JL, Toth E, De Serres G, Ménard S, Roussel R, Tremblay M et al (2004) Safety of revaccination of patients affected by the oculo-respiratory syndrome (ORS) following influenza vaccination. Can Commun Dis Rep 30:9–16PubMed
95.
Skowronski DM, Bjornson G, Husain E, Metzger DL, Scheifele DW (2005) Oculorespiratory syndrome after influenza immunization in children. Pediatr Infect Dis J 24:63–69PubMedCrossRef
96.
Hull TP, Bates JH (1997) Optic neuritis after influenza vaccination. Am J Ophthalmol 124:703–704PubMedCrossRef
97.
Perry HD, Mallen FJ, Grodin RW, Cossari AJ (1979) Reversible blindness in optic neuritis associated with influenza vaccination. Ann Ophthalmol 11:545–550PubMed
98.
Rubinov A, Beiran I, Krasnitz I, Miller B (2012) Bilateral optic neuritis after inactivated influenza vaccination. IMAJ 14:705–707PubMed
99.
Pillar G, Toubi E (2012) Vaccination-induced bilateral optic neuritis: rare but existing. IMAJ 14:690–691PubMed
100.
Blanche P, Decrette C, Sicard D (1994) Development of uveitis following vaccination for influenza. Clin Infect Dis 19:979PubMedCrossRef
101.
Tao Y, Chang L‑B, Zhao M, Li X‑X (2011) Two cases of exudative retina detachment and uveitis following H1N1 influenza vaccination. Chin Med J 124:3838–3840PubMed
102.
Solomon A, Siganos CS, Frucht-Pery J (1999) Adverse ocular effects following influenza vaccination. Eye 13(3a):381–382. doi:10.1038/eye.1999.101PubMedCrossRef
103.
Thurairajan G, Hope-Ross MW, Situnayake RD, Murray PI (1997) Polyarthropathy, orbital myositis and posterior scleritis: an unusual adverse reaction to influenza vaccine. Br J Rheumatol 36:120–123PubMedCrossRef
104.
Williams GS, Evans S, Yeo D, Al-bermani A (2015) Retinal artery vasculitis secondary to administration of influenza vaccine. BMJ Case Rep 2015. doi:10.1136/bcr-2015-211971
105.
Díez-Domingo J, Baldó J‑M, Planelles-Catarino MV, Garcés-Sánchez M, Ubeda I, Jubert-Rosich A et al (2015) Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination. Influenza Other Respir Viruses 9:68–77. doi:10.1111/irv.12295PubMedPubMedCentralCrossRef
106.
Wells MB, Garg S (2009) Bilateral panuveitis after influenza vaccination. Retin Cases Brief Rep 3:386–387. doi:10.1097/ICB.0b013e318193491bPubMedCrossRef
107.
Knopf HL (1991) Recurrent uveitis after influenza vaccination. Ann Ophthalmol 23:213–214PubMed
108.
Solomon A, Frucht-Pery J (1996) Bilateral simultaneous corneal graft rejection after influenza vaccination. Am J Ophthalmol 121:708–709PubMedCrossRef
109.
Goyal S, Nazarian SM, Thayi DR, Hammond F, Petrovic V (2013) Multiple evanescent white dot syndrome following recent influenza vaccination. J Can Ophtalmol 48:115–116. doi:10.1016/j.jcjo.2013.03.002CrossRef
110.
Mendrinos E, Baglivo E (2010) Acute posterior multifocal placoid pigment epitheliopathy following influenza vaccination. Eye 24:180–181. doi:10.1038/eye.2009.68PubMedCrossRef
111.
Kawasaki A, Purvin VA, Tang R (1998) Bilateral anterior ischemic optic neuropathy following influenza vaccination. J Neuroophthalmol 18: 56:59
112.
Ray CL, Dreizin IJ (1996) Bilateral optic neuropathy associated with influenza vaccination. J Neuroophthalmol 16:182–184PubMedCrossRef
113.
Khan AO (2009) Recurrent isolated sixth nerve palsy after consecutive annual influenza vaccination in a child. J AAPOS 13:623. doi:10.1016/j.jaapos.2009.08.005PubMedCrossRef
114.
Stangos A, Zaninetti M, Petropoulos I, Baglivo E, Pournaras C (2006) Multiple evanescent white dot syndrome following simultaneous hepatitis-A and yellow fever vaccination. Ocul Immunol Inflamm 14:301–304. doi:10.1080/09273940600932311PubMedCrossRef
Metadaten
Titel
Impfschäden am Auge
verfasst von
PD Dr. T. Ness
Prof. Dr. H. Hengel
Publikationsdatum
29.06.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Die Ophthalmologie / Ausgabe 7/2016
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI
https://doi.org/10.1007/s00347-016-0313-x

Weitere Artikel der Ausgabe 7/2016

Der Ophthalmologe 7/2016 Zur Ausgabe

Kasuistik

Lachsfarbener Bindehauttumor mit Amyloidablagerung

Leitthema

Konservative und chirurgische Therapie des Konvergenzexzesses

Kasuistiken

Low-grade-Endophthalmitis verursacht durch P. acnes

Leitthema

Zum Einsatz von Botulinumtoxin in der Strabologie

CME

CME: Nationale Versorgungsleitlinie (NVL) Diabetische Retinopathie

Leitthema

Strabologische und neuroophthalmologische Aspekte kindlicher Tumorerkrankungen

Passend zum Thema

ANZEIGE

IPD-Fallzahlen & Pneumokokken-Impfung bei Kindern in Deutschland

Das Niveau der postpandemischen Fallzahlen für invasive Pneumokokken-Erkrankungen (IPD) ist aus Sicht des Referenz-Zentrums für Streptokokken in Aachen alarmierend [1]. Wie sich die monatlichen IPD-Fallzahlen bei Kindern und Jugendlichen von Juli 2015 bis März 2023 entwickelt haben, lesen Sie hier.

ANZEIGE

HPV-Impfung: Auch für junge Erwachsene sinnvoll und wichtig

Auch nach dem 18. Lebensjahr kann eine HPV-Impfung sinnvoll und wichtig sein. Viele gesetzliche Krankenkassen übernehmen die Kosten auch zu einem späteren Zeitpunkt noch.

ANZEIGE

Impfstoffe – Krankheiten vorbeugen, bevor sie entstehen

Seit mehr als 130 Jahren entwickelt und produziert MSD Impfstoffe für alle Altersgruppen. Hier finden Sie nützliche Informationen und Praxismaterialien rund um das Thema Impfen.

MSD Sharp & Dohme GmbH
Bildnachweise